Title
In vivo protection against Tityus serrulatus scorpion venom by antibodies raised against a discontinuous synthetic epitope
Date Issued
03 February 2010
Access level
metadata only access
Resource Type
journal article
Author(s)
Duarte C.
Alvarenga L.
Dias-Lopes C.
Machado-de-Ávila R.
Nguyen C.
Molina F.
Granier C.
Universidad Federal de Minas Gerais
Abstract
Scorpion stings cause human fatalities in numerous countries. Serotherapy is the only specific means to try to circumvent the noxious effects of venom toxins. TsNTxP is a natural anatoxin from the venom of the scorpion Tityus serrulatus that may be useful to raise therapeutic anti-venom sera. Linear epitopes recognized by anti-TsNTxP antibodies have previously been mapped. Here, we attempted to identify discontinuous epitopes in TsNTxP since neutralizing epitopes are often associated with such complex entities. One hundred and fifty-three octadecapeptides with the general formula (P1)-(Gly-Gly)-(P2) were synthesized by the Spot method on cellulose membranes. P1 and P2 were octapeptides from the TsNTxP N-terminal and C-terminal sections, respectively. Each sequence of eight amino acids was frameshifted in turn by three residues, in order to cover TsNTxP entire sequence. Binding of neutralizing anti-TsNTxP rabbit antibodies to spotted peptides revealed GREGYPADGGGLPDSVKI as the more reactive peptide sequence. This epitope was made from the first eight residues of the protein (GREGYPAD) and from residues 47 to 54 (GLPDSVKI) of the C-terminal part of TsNTxP. BALB/c mice were immunized with synthetic GREGYPADGGGLPDSVKI peptide conjugated to ovalbumin. One week after the last immunization, in vivo protection assays showed that immunized mice could resist a challenge by an amount of T. serrulatus whole venom equivalent to 1.75 LD100, a dose that killed all control non-immune mice. Based on molecular models of TsNTxP and related Tityus toxins, we found that the above peptide matches with a discontinuous epitope, well exposed at the toxin molecular surface which contains residues known to be important for the bioactivity of toxins. © 2009.
Start page
1168
End page
1176
Volume
28
Issue
5
Language
English
OCDE Knowledge area
Toxicología Inmunología
Scopus EID
2-s2.0-74349102619
PubMed ID
Source
Vaccine
ISSN of the container
0264410X
Sponsor(s)
Funding text This research was supported by Fundação de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), by funds of the INCTTOX PROGRAM of Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil (CNPq) and Fundação de Amparo a Pesquisa do Estado de São Paulo, Brazil (FAPESP) and Coordenação de Aperfeiçoamento Pessoal de Nível Superior/Comité Français d’evaluation de la Cooperation Universitaire avec le Brésil (CAPES/COFECUB-Brazil/France) . Technical assistance provided by Núcleo de Biomoléculas in Mass Spectrometry Analysis, Universidade Federal de Minas Gerais, is gratefully acknowledged.
Sources of information: Directorio de Producción Científica Scopus